Skip to main content
SpringerLink
Log in

Neuroimmunology of Atopic Dermatitis

  • Chapter
Neuroimmunology of the Skin

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Abbreviations

ACh :

Acetylcholine

AD :

Atopic dermatitis

BDNF :

Brain-derived neurotrophic factor

CB :

Cannabinoid

CGRP :

Calcitonin gene related peptide

CNS :

Central nervous system

Derf Dermatophagoides farinae, FK506 :

Immunosuppressant that prolongs allograft survival

H4R :

Histamine receptor-4

H3R :

Histamine receptor-3

HMC-I :

Human mast cell line

HU210 :

Synthetic cannabinoid agonist

IFN-ϕ :

Interferon-γ

IL :

Interleukin

MIF :

Macrophage migration inhibitory factor

MSH :

Melanocyte-stimulating hormone

NGF :

Nerve growth factor

NK1R :

Neurokinin-1-receptor

NT4/NT3 :

Neurotrophin-4/neurotrophin-3

PACAP :

Pituitary adenylate cyclase activating polypeptide

PAR :

Proteinase-activated receptor

POMC :

Proopio-melano-corticotropin

RA :

Rheumatoid arthritis

RT PCR :

Reverse transcription polymerase chain reaction

SMS :

Somatostatin-derived peptide

SP :

Substance P

SST :

Somatostatin

TH :

T-helper cell

trk :

Tropomyosin-related kinase receptors

TRPV1 :

Transient receptor potential vanilloid type-1

VIP :

Vasoactive intestinal peptide

References

  1. Akerman S, Kaube H, Goadsby PJ (2004) Anandamide acts as a vasodilator of durai blood vessels in vivo by activating TRPV1 receptors. Br J Pharmacol 142:1354–1360

    Article  PubMed  CAS  Google Scholar 

  2. Andoh T, Nagasawa T, Satoh M, Kuraishi Y (1998) Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice. J Pharmacol Exp Ther 286:1140–1145

    PubMed  CAS  Google Scholar 

  3. Banvolgyi A, Palinkas L, Berki T, Clark N, Grant AD, Helyes Z, Pozsgai G, Szolcsanyi J, Brain SD, Pinter E (2005) Evidence for a novel protective role of the vanilloid TRPV1 receptor in a cutaneous contact allergic dermatitis model. J Neuroimmunol 169:86–96

    Article  PubMed  CAS  Google Scholar 

  4. Barak LS, Oakley RH, Laporte SA, Caron MG (2001) Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. Proc Natl Acad Sci USA 98:93–98

    Article  PubMed  CAS  Google Scholar 

  5. Bell JK, McQueen DS, Rees JL (2004) Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice. Br J Pharmacol 142:374–380

    Article  PubMed  CAS  Google Scholar 

  6. Bennett LA, Johnson JM, Stephens DP, Saad AR, Kellogg DL Jr. (2003) Evidence for a role for vasoactive intestinal peptide in active vasodilatation in the cutaneous vasculature of humans. J Physiol 552:223–232

    Article  PubMed  CAS  Google Scholar 

  7. Bergasa NV, Talbot TL, Ailing DW, Schmitt JM, Walker EC, Baker BL, Korenman JC, Park Y, Hoofnagle JH, Jones EA (1992) A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 102:544–549

    PubMed  CAS  Google Scholar 

  8. Bigliardi-Qi M, Sumanovski LT, Buchner S, Rufli T, Bigliardi PL (2004) Mu-opiate receptor and Beta-endorphin expression in nerve endings and keratinocytes in human skin. Dermatology 209:183–189

    Article  PubMed  CAS  Google Scholar 

  9. Bigliardi-Qi M, Lipp B, Sumanovski LT, Buechner SA, Bigliardi PL (2005) Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis. Dermatology 210:91–99

    Article  PubMed  CAS  Google Scholar 

  10. Biro JC, Benyo B, Sansom C, Szlavecz A, Fordos G, Micsik T, Benyo Z (2003) A common periodic table of codons and amino acids. Biochem Biophys Res Commun 306:408–415

    Article  PubMed  CAS  Google Scholar 

  11. Biro T, Acs G, Acs P, Modarres S, Blumberg PM (1997) Recent advances in understanding of vanilloid receptors: a therapeutic target for treatment of pain and inflammation in skin. J Investig Dermatol Symp Proc 2:56–60

    PubMed  CAS  Google Scholar 

  12. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, Haugen HS, Maurer M, Harder B, Johnston J, Bort S, Mudri S, Kuijper JL, Bukowski T, Shea P, Dong DL, Dasovich M, Grant FJ, Lockwood L, Levin SD, LeCiel C, Waggie K, Day H, Topouzis S, Kramer J, Kuestner R, Chen Z, Foster D, Parrish-Novak J, Gross JA (2004) Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5:752–760

    Article  PubMed  CAS  Google Scholar 

  13. Dvorak M, Watkinson A, McGlone F, Rukwied R (2003) Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin. Inflamm Res 52:238–245

    PubMed  CAS  Google Scholar 

  14. Fjellner B, Hagermark O (1981) Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters. Acta Derm Venereol 61:245–250

    PubMed  CAS  Google Scholar 

  15. Fjellner B, Hagermark O (1982) Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK-33–824, beta-endorphin and morphine. Arch Dermatol Res 274:29–37

    Article  PubMed  CAS  Google Scholar 

  16. Frucht-Pery J, Feldman ST, Brown SI (1997) The use of capsaicin in herpes zoster ophthalmicus neuralgia. Acta Ophthalmol Scand 75:311–313

    Article  PubMed  CAS  Google Scholar 

  17. Glinski W, Brodecka H, Glinska-Ferenz M, Kowalski D (1994) Increased concentration of beta-endorphin in sera of patients with psoriasis and other inflammatory dermatoses. Br J Dermatol 131:260–264

    Article  PubMed  CAS  Google Scholar 

  18. Grewe M, Vogelsang K, Ruzicka T, Stege H, Krutmann J (2000) Neurotrophin-4 production by human epidermal keratinocytes: increased expression in atopic dermatitis. J Invest Dermatol 114:1108–1112

    Article  PubMed  CAS  Google Scholar 

  19. Groneberg DA, Welker P, Fischer TC, Dinh QT, Grutzkau A, Peiser C, Wahn U, Henz BM, Fischer A (2003) Downregulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis. J Allergy Clin Immunol 111:1099–1105

    Article  PubMed  CAS  Google Scholar 

  20. Groneberg DA, Bester C, Grutzkau A, Serowka F, Fischer A, Henz BM, Welker P (2005) Mast cells and vasculature in atopic dermatitis — potential stimulus of neoangiogenesis. Allergy 60:90–97

    Article  PubMed  CAS  Google Scholar 

  21. Heyer G, Hornstein OP, Handwerker HO (1989) Skin reactions and itch sensation induced by epicutaneous histamine application in atopic dermatitis and controls. J Invest Dermatol 93:492–496

    Article  PubMed  CAS  Google Scholar 

  22. Heyer G, Ulmer FJ, Schmitz J, Handwerker HO (1995) Histamine-induced itch and alloknesis (itchy skin) in atopic eczema patients and controls. Acta Derm Venereol 75:348–352

    PubMed  CAS  Google Scholar 

  23. Heyer G, Koppert W, Martus P, Handwerker HO (1998) Histamine and cutaneous nociception: histamine-induced responses in patients with atopic eczema, psoriasis and urticaria. Acta Derm Venereol 78:123–126

    Article  PubMed  CAS  Google Scholar 

  24. Heyer GR, Hornstein OP (1999) Recent studies of cutaneous nociception in atopic and non-atopic subjects. J Dermatol 26:77–86

    PubMed  CAS  Google Scholar 

  25. Hollenberg MD, Compton SJ (2002) International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev 54:203–217

    Article  PubMed  CAS  Google Scholar 

  26. Hossen MA, Sugimoto Y, Kayasuga R, Kamei C (2003) Involvement of histamine H3 receptors in scratching behaviour in mast cell-deficient mice. Br J Dermatol 149:17–22

    Article  PubMed  CAS  Google Scholar 

  27. Hsieh JC, Hagermark O, Stahle-Backdahl M, Ericson K, Eriksson L, Stone-Elander S, Ingvar M (1994) Urge to scratch represented in the human cerebral cortex during itch. J Neurophysiol 72:3004–3008

    PubMed  CAS  Google Scholar 

  28. Husz S, Toth-Kasa I, Kiss M, Dobozy A (1994) Treatment of cold urticaria. Int J Dermatol 33:210–213

    PubMed  CAS  Google Scholar 

  29. Ibrahim MM, Porreca F, Lai J, Albrecht PJ, Rice FL, Khodorova A, Davar G, Makriyannis A, Vanderah TW, Mata HP, Malan TP Jr. (2005) CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci USA 102:3093–3098

    Article  PubMed  CAS  Google Scholar 

  30. Jarvikallio A, Harvima IT, Naukkarinen A (2003) Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 295:2–7

    PubMed  Google Scholar 

  31. Johansson O, Liu PY, Bondesson L, Nordlind K, Olsson MJ, Lontz W, Verhofstad A, Liang Y, Gangi S (1998) A serotonin-like immunoreactivity is present in human cutaneous melanocytes. J Invest Dermatol 111:1010–1014

    Article  PubMed  CAS  Google Scholar 

  32. Johnson GD, Stevenson T, Ahn K (1999) Hydrolysis of peptide hormones by endothelin-converting enzyme-1. A comparison with neprilysin. J Biol Chem 274:4053–4058

    Article  PubMed  CAS  Google Scholar 

  33. Jones EA, Bergasa NV (1992) The pruritus of cholestasis and the opioid system [clinical conference]. JAMA 268: 3359–3362

    Article  PubMed  CAS  Google Scholar 

  34. Jones EA, Bergasa NV (1999) The pruritus of cholestasis [In Process Citation]. Hepatology 29:1003–1006

    Article  PubMed  CAS  Google Scholar 

  35. Kaminska R, Naukkarinen A, Horsmanheimo M, Harvima IT (1999) Suction blister formation in skin after acute and repeated mast cell degranulation. Acta Derm Venereol 79:191–194

    Article  PubMed  CAS  Google Scholar 

  36. Katsuno M, Aihara M, Kojima M, Osuna H, Hosoi J, Nakamura M, Toyoda M, Matsuda H, Ikezawa Z (2003) Neuropeptides concentrations in the skin of a murine (NC/Nga mice) model of atopic dermatitis. J Dermatol Sci 33:55–65

    Article  PubMed  CAS  Google Scholar 

  37. Klein TW (2005) Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 5:400–411

    Article  PubMed  CAS  Google Scholar 

  38. Kofler B, Berger A, Santic R, Moritz K, Almer D, Tuechler C, Lang R, Emberger M, Klausegger A, Sperl W, Bauer JW (2004) Expression of neuropeptide galanin and galanin receptors in human skin. J Invest Dermatol 122:1050–1053

    Article  PubMed  CAS  Google Scholar 

  39. Lazar J, Szabo T, Kovacs L, Blumberg PM, Biro T (2003) Distinct features of recombinant rat vanilloid receptor-1 expressed in various expression systems. Cell Mol Life Sci 60:2228–2240

    Article  PubMed  CAS  Google Scholar 

  40. Lotti T, Teofoli P, Tsampau D (1994) Treatment of aquagenic pruritus with topical capsaicin cream. J Am Acad Dermatol 30:232–235

    Article  PubMed  CAS  Google Scholar 

  41. Maccarrone M, Di Rienzo M, Battista N, Gasperi V, Guerrieri P, Rossi A, Finazzi-Agro A (2003) The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem 278:33896–33903

    Article  PubMed  CAS  Google Scholar 

  42. Menke JJ, Heins JR (1999) Treatment of postherpetic neuralgia. J Am PharmAssoc (Wash) 39:217–221

    CAS  Google Scholar 

  43. Misery L (1998) Langerhans cells in the neuro-immuno-cutaneous system. J Neuroimmunol 89:83–87

    Article  PubMed  CAS  Google Scholar 

  44. Neis MM, Peters B, Dreuw A, Wenzel J, Bieber T, Mauch C, Krieg T, Stanzel S, Heinrich PC, Merk HF, Bosio A, Baron JM, Hermanns HM (2006) Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 118:930–937

    Article  PubMed  CAS  Google Scholar 

  45. Nockher WA, Renz H (2006) Neurotrophins in allergic diseases: from neuronal growth factors to intercellular signaling molecules. J Allergy Clin Immunol 117:583–589

    Article  PubMed  CAS  Google Scholar 

  46. Ossovskaya VS, Bunnett NW (2004) Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84:579–621

    Article  PubMed  CAS  Google Scholar 

  47. Ostlere LS, Cowen T, Rustin MH (1995) Neuropeptides in the skin of patients with atopic dermatitis. Clin Exp Dermatol 20:462–467

    Article  PubMed  CAS  Google Scholar 

  48. Paus R, Schmelz M, Biro T, Steinhoff M (2006) Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest 116:1174–1186

    Article  PubMed  CAS  Google Scholar 

  49. Paus R, Schmelz M, Biro T, Steinhoff M (2006) Scratching the brain for more effective “itch” therapy — Frontiers in pruritus research. J Clin Invest 116:1174–1186

    Article  PubMed  CAS  Google Scholar 

  50. Perego C, Lattuada D, Casnici C, Gatti S, Orsenigo R, Panagiotis S, Franco P, Marelli O (1998) Study of the immunosuppressive effect of SMS 201–995 and its synergic action with FK 506. Transplant Proc 30:2182–2184

    Article  PubMed  CAS  Google Scholar 

  51. Pincelli C, Fantini F, Massimi P, Girolomoni G, Seidenari S, Giannetti A (1990) Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br J Dermatol 122:745–750

    Article  PubMed  CAS  Google Scholar 

  52. Raap U, Kapp A (2005) Neuroimmunological findings in allergic skin diseases. Curr Opin Allergy Clin Immunol 5:419–424

    Article  PubMed  CAS  Google Scholar 

  53. Richardson JD, Aanonsen L, Hargreaves KM (1998) Antihy-peralgesic effects of spinal cannabinoids. Eur J Pharmacol 345:145–153

    Article  PubMed  CAS  Google Scholar 

  54. Richardson JD, Kilo S, Hargreaves KM (1998) Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75:111–119

    Article  PubMed  CAS  Google Scholar 

  55. Ross DR, Varipapa RJ (1989) Treatment of painful diabetic neuropathy with topical capsaicin [letter] [see comments]. N Engl J Med 321:474–475

    Article  PubMed  CAS  Google Scholar 

  56. Rukwied R, Heyer G (1998) Cutaneous reactions and sensations after intracutaneous injection of vasoactive intestinal polypeptide and acetylcholine in atopic eczema patients and healthy controls. Arch Dermatol Res 290:198–204

    Article  PubMed  CAS  Google Scholar 

  57. Rukwied R, Heyer G (1999) Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients. Exp Dermatol 8:39–45

    Article  PubMed  CAS  Google Scholar 

  58. Rukwied R, Watkinson A, McGlone F, Dvorak M (2003) Cannabinoid agonists attenuate capsaicin-induced responses in human skin. Pain 102:283–288

    Article  PubMed  CAS  Google Scholar 

  59. Rupprecht M, Hornstein OP, Schluter D, Schafers HJ, Koch HU, Beck G, Rupprecht R (1995) Cortisol, corticotropin, and beta-endorphin responses to corticotropin-releasing hormone in patients with atopic eczema. Psychoneuroendocrinology 20:543–551

    Article  PubMed  CAS  Google Scholar 

  60. Rupprecht M, Salzer B, Raum B, Hornstein OP, Koch HU, Riederer P, Sofic E, Rupprecht R (1997) Physical stress-induced secretion of adrenal and pituitary hormones in patients with atopic eczema compared with normal controls. Exp Clin Endocrinol Diabetes 105:39–45

    Article  PubMed  CAS  Google Scholar 

  61. Sabroe RA, Kennedy CT, Archer CB (1997) The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin. Br J Dermatol 137:386–390

    Article  PubMed  CAS  Google Scholar 

  62. Schallreuter KU, Pittelkow MR, Swanson NN, Beazley WD, Korner C, Ehrke C, Buttner G (1997) Altered catecholamine synthesis and degradation in the epidermis of patients with atopic eczema. Arch Dermatol Res 289:663–666

    Article  PubMed  CAS  Google Scholar 

  63. Schmelz M (2001) A neural pathway for itch. Nat Neurosci 4:9–10

    Article  PubMed  CAS  Google Scholar 

  64. Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjork HE (1997) Specific C-receptors for itch in human skin. J Neurosci 17:8003–8008

    PubMed  CAS  Google Scholar 

  65. Schmidhuber SM, Santic R, Tarn CW, Bauer JW, Kofler B, Brain SD (2007) Galanin-like peptides exert potent vasoactive functions in vivo. J Invest Dermatol 127:716–721

    Article  PubMed  CAS  Google Scholar 

  66. Shelley WB, Arthur RP (1957) The neurohistology and neurophysiology of the itch sensation in man. AMA Arch Derm 76:296–323

    PubMed  CAS  Google Scholar 

  67. Singh ME, McGregor IS, Mallet PE (2005) Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity. Neuropharmacology 49:1189–1200

    Article  PubMed  CAS  Google Scholar 

  68. Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, Alenius H, Dieu-Nosjean MC, Meller S, Rieker J, Steinhoff M, Hoffmann TK, Ruzicka T, Zlotnik A, Homey B (2006) IL-31 : a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 117:411–417

    Article  PubMed  CAS  Google Scholar 

  69. Stander S, Steinhoff M (2002) Pathophysiology of pruritus in atopic dermatitis: an overview. Exp Dermatol 11:12–24

    Article  PubMed  CAS  Google Scholar 

  70. Stander S, Gunzer M, Metze D, Luger T, Steinhoff M (2002) Localization of micro-opioid receptor 1A on sensory nerve fibers in human skin. Regul Pept 110:75–83

    Article  PubMed  CAS  Google Scholar 

  71. Stander S, Schmelz M, Metze D, Luger T, Rukwied R (2005) Distribution of cannabinoid receptor I (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J Dermatol Sci 38:177–188

    Article  PubMed  CAS  Google Scholar 

  72. Staniek V, Liebich C, Vocks E, Odia SG, Doutremepuich JD, Ring J, Claudy A, Schmitt D, Misery L (1998) Modulation of cutaneous SP receptors in atopic dermatitis after UVA irradiation. Acta Derm Venereol 78:92–94

    Article  PubMed  CAS  Google Scholar 

  73. Steinhoff M, Stander S, Seeliger S, Ansel JC, Schmelz M, Luger T (2003) Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol 139:1479–1488

    Article  PubMed  Google Scholar 

  74. Steinhoff M, Neisius U, Ikoma A, Fartasch M, Heyer G, Skov PS, Luger TA, Schmelz M (2003) Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 23:6176–6180

    PubMed  CAS  Google Scholar 

  75. Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, Vergnolle N, Luger TA, Hollenberg MD (2005) Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 26:1–43

    Article  PubMed  CAS  Google Scholar 

  76. Steinhoff M, Bienenstock J, Schmelz M, Maurer M, Wei E, Biro T (2006) Neurophysiological, neuroimmunological and neuroen-docrine basis of pruritus. J Invest Dermatol 1268:1705–1718

    Article  CAS  Google Scholar 

  77. Steinhoff M, Steinhoff A, Homey B, Luger TA, Schneider SW (2006) Role of vasculature in atopic dermatitis. J Allergy Clin Immunol 118:190–197

    Article  PubMed  CAS  Google Scholar 

  78. Sugiura H, Omoto M, Hirota Y, Danno K, Uehara M (1997) Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis. Arch Dermatol Res 289:125–131

    Article  PubMed  CAS  Google Scholar 

  79. Szolcsanyi J, Sandor Z, Petho G, Varga A, Bolcskei K, Almasi R, Riedl Z, Hajos G, Czeh G (2004) Direct evidence for activation and desensitization of the capsaicin receptor by N-oleoyldopamine on TRPVl-transfected cell, line in gene deleted mice and in the rat. Neurosci Lett 361:155–158

    Article  PubMed  CAS  Google Scholar 

  80. Thomas DA, Williams GM, Iwata K, Kenshalo DR Jr., Dubner R (1992) Effects of central administration of opioids on facial scratching in monkeys. Brain Res 585:315–317

    Article  PubMed  CAS  Google Scholar 

  81. Thomas DA, Oliveras JL, Maixner W, Dubner R (1992) Systemic morphine administration attenuates the perceived intensity of noxious heat in the monkey. Pain 49:129–135

    Article  PubMed  CAS  Google Scholar 

  82. Toyoda M, Morohashi M (1998) Morphological assessment of the effects of cyclosporin A on mast cell — nerve relationship in atopic dermatitis. Acta Derm Venereol 78:321–325

    Article  PubMed  CAS  Google Scholar 

  83. Ui H, Andoh T, Lee JB, Nojima H, Kuraishi Y (2006) Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice. Eur J Pharmacol 530:172–178

    Article  PubMed  CAS  Google Scholar 

  84. Umemoto N, Kakurai M, Okazaki H, Kiyosawa T, Demitsu T, Nakagawa H (2003) Serum levels of vasoactive intestinal peptide are elevated in patients with atopic dermatitis. J Dermatol Sci 31:161–164

    Article  PubMed  CAS  Google Scholar 

  85. Urashima R, Mihara M (1998) Cutaneous nerves in atopic dermatitis. A histological, immunohistochemical and electron microscopic study. Virchows Arch 432:363–370

    Article  PubMed  CAS  Google Scholar 

  86. van der Stelt M, Trevisani M, Vellani V, De Petrocellis L, Schiano Moriello A, Campi B, McNaughton P, Geppetti P, Di Marzo V (2005) Anandamide acts as an intracellular messenger amplifying Ca2 + influx via TRPV1 channels. EMBO J 24:3026–3037

    Article  PubMed  CAS  Google Scholar 

  87. Wahlgren CF (1992) Pathophysiology of itching in urticaria and atopic dermatitis. Allergy 47:65–75

    PubMed  CAS  Google Scholar 

  88. Wahlgren CF (1995) Measurement of itch. Semin Dermatol 14:277–284

    Article  PubMed  CAS  Google Scholar 

  89. Wallengren J (2005) Neuroanatomy and neurophysiology of itch. Dermatol Ther 18:292–303

    PubMed  Google Scholar 

  90. Wallengren J, Moller H (1986) The effect of capsaicin on some experimental inflammations in human skin. Acta Derm Venereol 66:375–380

    PubMed  CAS  Google Scholar 

  91. Weisshaar E, Forster C, Dotzer M, Heyer G (1997) Experimentally induced pruritus and cutaneous reactions with topical antihistamine and local analgesics in atopic eczema. Skin Pharmacol 10:183–190

    Article  PubMed  CAS  Google Scholar 

  92. Weisshaar E, Heyer G, Forster C, Handwerker HO (1998) Effect of topical capsaicin on the cutaneous reactions and itching to histamine in atopic eczema compared to healthy skin. Arch Dermatol Res 290:306–311

    Article  PubMed  CAS  Google Scholar 

  93. Yokote R, Yagi H, Furukawa F, Takigawa M (1998) Regulation of peripheral blood mononuclear cell responses to Dermatophagoides farinae by substance P in patients with atopic dermatitis. Arch Dermatol Res 290:191–197

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Münster, Münster, Germany

    A. Steinhoff

  2. Department of Dermatology and Boltzmann Institute for Immunobiology of the Skin, University Hospital Münster, Von-Esmarch-Str. 58, 48149, Münster, Germany

    M. Steinhoff

Authors
  1. A. Steinhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Steinhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Steinhoff .

Editor information

Editors and Affiliations

  1. Weill Cornell Medical College Department of Dermatology, Cornell University, 1300 York Ave., 10021, New York, NY, USA

    Richard D. Granstein MD

  2. Medizinische Einrichtungen Klinik und Poliklinik für, Universitätsklinikum Münster, Von-Esmarch-Str. 56, 48149, Münster, Germany

    Thomas A. Luger MD

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Steinhoff, A., Steinhoff, M. (2009). Neuroimmunology of Atopic Dermatitis. In: Granstein, R.D., Luger, T.A. (eds) Neuroimmunology of the Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-35989-0_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-35989-0_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-35986-9

  • Online ISBN: 978-3-540-35989-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation